Thoracic
Pulmonology
Lung Cancer Screening Can Be Effective In High Risk Population Thursday, 30 December 2010 04:05 |   
|
||||||
|
Lung cancer screening using
More research is suggesting that heavy smokers may benefit from screening for lung cancer, to detect tumors in their earliest stages.
Data from two studies proves that augmentation therapy with Alpha(1)-Proteinase Inhibitor (Human) (A1PI) greatly reduces lung tissue loss in patients with emphysema related to AAT deficiency.
Updated results from a study published last year show that patients with massive pulmonary embolism (PE) treated with ultrasound-accelerated catheter-directed thrombolysis continue to show benefit 1 year later.
- LCA Hails NCI Announcement on CT Screening as Seminal Moment for the Lung Cancer Community
- Statement of the ACR on the National Lung Cancer Screening Trial
- CT Scans Modestly Cut Lung Cancer Deaths
- Annual CT Lung Screening Saves Lives
- VIDA Diagnostics Introduces Apollo
- Abstracts Reporting EarlyCDT Biomarkers in Early Detection of Lung Cancers
- Pre-Treatment Radiation Poses No Risks to Prostate, Lung Cancer Patients
- Deep Breeze Launches VRIxp Lung Imaging System
- New Study Demonstrates Clinical Validity of EarlyCDT-Lung
- Faster Tracking of Lung Tumors Helps Treatment
- New 3-D imaging techniques for improved lung cancer drug development
- Genetic screening may redefine medical treatments
- Pricey lung disease drugs have no benefit
- Lung Cancer Alliance Program Helps in a New Approach for Risk in Smokers and Non-Smokers
- Docs Should Assess Lung Clot Risk Before Ordering Scan
- CT Angiography Unnecessary For Patients with Pulmonary Embolism
- Overview Of chILD In Special Issue
- Ruedi Waeger Receives the 2010 Robert W. Reilly Leadership Award
- Researchers create 'lung-on-a-chip'
- CT showed dose variability in National Lung Screening Trial
